Improve inspiratory strength and fitness
- Trial ID
- NCT07010783
- Official Title
- Investigation of Respiratory Functions, Inspiratory Muscle Strength, Physical Fitness and Aerobic Capacity in Patients With Parkinson's Disease
- Goal
- Improve inspiratory strength and fitness
- Status
- RECRUITING
- Sponsor
- Ankara University
- Study Type
- OBSERVATIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease
Plain-Language Summary
Researchers are mapping how Parkinson's affects breathing and exercise capacity, aiming to clarify problems with respiratory function and inspiratory muscle strength that can make daily activity harder and guide rehab and safety. Participants will have noninvasive tests of lung function, measurements of how much pressure the inspiratory muscles can generate, and fitness or aerobic capacity tests that show how well the heart and lungs support activity, no drug or device is given. Adults 50 to 80 with a neurologist-confirmed Parkinson's diagnosis and a Mini Mental State Examination score of 24 to 30 can join, while people who cannot communicate verbally, who use a walking aid, who have severe vision problems or other neurological disease, who have congestive heart failure, or who are not cleared to exercise are excluded.
Locations
- Atılım University, Ankara, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. Researchers are mapping how Parkinson's affects breathing and exercise capacity, aiming to clarify problems with respiratory function and inspiratory muscle strength that can make daily activity harder and guide rehab and safety. Participants will have noninvasive tests of lung function, measurements of how much pressure the inspiratory muscles can generate, and fitness or aerobic capacity tests that show how well the heart and lungs support activity, no drug or device is given. Adults 50 to 80 with a neurologist-confirmed Parkinson's diagnosis and a Mini Mental State Examination score of 24 to 30 can join, while people who cannot communicate verbally, who use a walking aid, who have severe vision problems or other neurological disease, who have congestive heart failure, or who are not cleared to exercise are excluded.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 9 months.